Articles From: Eastmain Resources Inc.: Lac Lessard Project Nickel-Copper-PGM Mineralization Confirmed to EUROPE MARKETS: Euro Falls, Stocks Flat After Fresh Round Of Downbeat Data


http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0970710001&sourceType=1 http://www.ccnmatthews.com/logos/20100923-es200.jpg TORONTO, ONTARIO --
Sign-up for Eastmain Resources Inc.: Lac Lessard Project Nickel-Copper-PGM Mineralization Confirmed investment picks
2014/10/1
eBay Canada report suggests removal of trade barriers to support growing cohort of avid exporters Canada NewsWire TORONTO , Oct.
Sign-up for eBay Canada report suggests removal of trade barriers to support growing cohort of avid exporters investment picks
Echelon Corporation (NASDAQ:ELON), the open-interoperable control networking pioneer for the Industrial Internet of Things (IIoT), today announced the completion of the sale of its grid operations to S&T AG, a publicly traded European IT systems provider with an existing focus on smart energy products and services.
Sign-up for Echelon Completes Sale of Its Grid Division investment picks
2014/10/1
Ecolab will host a live webcast of its third quarter earnings conference call to discuss third quarter results and future earnings guidance.
Sign-up for Ecolab Schedules Webcast and Conference Call on October 28 investment picks
Ellie Mae® (NYSE:ELLI), a leading provider of innovative on-demand software solutions and services for the residential mortgage industry, announced today that it has completed its acquisition of AllRegs, a leading information provider for the mortgage industry.
Sign-up for Ellie Mae Completes AllRegs Acquisition investment picks
EMC Shipped Most Terabytes for Enterprise Storage Supporting Major Enterprise Applications HOPKINTON, Mass.
Sign-up for EMC Named #1 Most-Shipped Storage for Mission-Critical Applications investment picks
2014/10/1
On Friday, October 10th, Bethel Woods Center for the Arts will host its third annual Wine Pairing Dinner, which has been underwritten by Montreign Operating Company, LLC (“Montreign”), a wholly-owned subsidiary of Empire Resorts, Inc. (NASDAQ-GM:NYNY). The sold-out event is the not-for-profit's primary annual fundraiser and the money raised helps support the organization's mission to inspire, educate, and empower through the arts and humanities.
Sign-up for Empire Resorts Subsidiary Sponsors Bethel Woods Third Annual Wine Pairing Fundraiser investment picks
Empire State Realty Trust, Inc. (NYSE:ESRT) (the “Company”), today announced that the Company will release its third quarter financial results on Wednesday, October 29, 2014 after close of markets on the New York Stock Exchange.
Sign-up for Empire State Realty Trust Announces Dates for Third Quarter Earnings Release and Conference Call investment picks
Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that 25 abstracts reporting the results of hepatitis C virus (HCV) treatment regimens containing ABT-450, Enanta’s lead protease inhibitor, or ABT-493, Enanta’s next-generation protease inhibitor, have been accepted for presentation at The Liver Meeting, the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), being held November 7-11, 2014 in Boston, MA.
Sign-up for Enanta Pharmaceuticals Announces Data Presentations on Regimens Containing ABT-450 or ABT-493 to be Presented at the American Association for the Study of Liver Diseases (AASLD) investment picks
Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that the company has entered into an agreement to regain full rights from Novartis to EDP-239, an NS5A inhibitor currently in phase 1 development for hepatitis C virus (HCV). “Novartis notified Enanta that as part of an ongoing portfolio transformation, HCV research would no longer be a strategic focus for Novartis,” stated Jay R.
Sign-up for Enanta Regains Full Rights to NS5A Inhibitor EDP-239 for Hepatitis C Virus from Novartis investment picks
ENSCO PLC (ESV) filed a Form 8K - Other Events - with the U.S Securities and Exchange Commission on September 30, 2014.
Sign-up for Ensco Files 8K - Other Events investment picks
2014/10/1
Enterprise Products Partners L.P. (NYSE: EPD, “Enterprise”) announced today that it has acquired the general partner and related incentive distribution rights, 15,899,802 common units and 38,899,802 subordinated units in Oiltanking Partners L.P. (NYSE: OILT, “Oiltanking Partners”) held by Oiltanking Holding Americas, Inc. (“Oiltanking Holding”). Enterprise paid total consideration of approximately $4.41 billion to Oiltanking Holding comprised of $2.21 billion in cash and 54,807,352 Enterprise common units.
Sign-up for Enterprise Products Acquires the General Partner and LP Interests in Oiltanking Partners; Proposes Merger of Oiltanking into Enterprise investment picks
Envestnet , Inc. (NYSE:ENV), a leading provider of unified wealth management technology and services to investment advisors and wealth managers, announced today that it has completed the acquisition of Placemark Holdings, Inc., a leading developer of Unified Managed Accounts (UMA) programs for banks, full-service broker-dealers and RIA firms.
Sign-up for Envestnet Completes Acquisition of Placemark Investments investment picks
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced, in conjunction with its development partner Eisai, that clinical data from the ongoing Phase 1 study of EPZ-6438 (E7438), an oral, small molecule inhibitor of EZH2, will be featured in a late-breaking oral presentation at the 26 th EORTC-AACR-NCI Symposium on Molecular Targets and Cancer Therapeutics, to be held November 18-21 in Barcelona, Spain.
Sign-up for Epizyme Announces Clinical Data from Phase 1 Trial of EZH2 Inhibitor EPZ-6438 (E7438) to be Presented at EORTC-NCI-AACR Symposium investment picks
Management Internalization Now Complete CBRE Group, Inc. Assumes Property Management for U.S. Assets CHICAGO , Oct.
Sign-up for Equity Commonwealth Terminates External Management Agreements investment picks
Esperion Therapeutics Inc. (ESPR) reported favorable trial data for a cholesterol-reduction drug, pushing shares up sharply after hours.
Sign-up for Esperion Reports Favorable Cholesterol Drug Data investment picks
By Josh Beckerman Esperion Therapeutics Inc. (ESPR) reported favorable trial data for a cholesterol-reduction drug, pushing shares up sharply after hours.
Sign-up for Esperion Reports Favorable Cholesterol Drug Data -- Update investment picks
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch) -- Shares of Esperion Therapeutics Inc. rallied after the drug developer said its treatment significantly lowered bad cholesterol in patients enrolled in a clinical trial.
Sign-up for Esperion shares rally on cholesterol drug study investment picks
Esperion Therapeutics Inc. (ESPR) shares rallied in the extended session Wednesday after the drug developer said a mid-stage clinical trial showed its drug candidate significantly lowered bad cholesterol.
Sign-up for Esperion shares rally on cholesterol drug study results investment picks
Esperion Therapeutics, Inc. (NASDAQ: ESPR), an emerging pharmaceutical company focused on developing and commercializing first-in-class, oral low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies for the treatment of hypercholesterolemia and other cardiometabolic risk markers, today announced positive top-line results from ETC-1002-008, a Phase 2b study evaluating the efficacy and safety of ETC-1002 monotherapy compared with ezetimibe monotherapy in patients with hypercholesterolemia, with or without statin intolerance.
Sign-up for Esperion Therapeutics Announces Positive Top-Line Phase 2b Results for ETC-1002, An Investigational Therapy for Patients with Hypercholesterolemia investment picks
2014/10/1
Essent Guaranty, Inc., a nationwide provider of mortgage insurance (MI), announced today that it is now offering lenders access to Essent MI for delegated and non-delegated loans and rate quotes through ISGN’s MORvision Plug-In Partner Network.
Sign-up for Essent Guaranty and ISGN Announce Access to MI through MORvision Plug-In Partner Network investment picks
2014/10/1
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European equities stuck close to the flatline and the euro languished at two-year lows against the dollar on Wednesday, as economic data highlighted the growth challenges the European Central Bank likely will address at its meeting tomorrow.
Sign-up for Euro falls, stocks flat after fresh round of downbeat data investment picks
2014/10/1
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European equities stuck close to the flatline and the euro languished at two-year lows against the dollar on Wednesday, as economic data highlighted the growth challenges the European Central Bank likely will address at its meeting tomorrow.
Sign-up for EUROPE MARKETS: Euro Falls, Stocks Flat After Fresh Round Of Downbeat Data investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Eastmain Resources Inc.: Lac Lessard Project Nickel-Copper-PGM Mineralization Confirmed to EUROPE MARKETS: Euro Falls, Stocks Flat After Fresh Round Of Downbeat Data
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices